DLC1 Is a Prognosis-Related Biomarker Correlated With Tumor ...
www.frontiersin.org › articles › full
Background and AimDeleted in liver cancer 1 (DLC1) is confirmed as a metastasis suppressor gene in endometrial carcinoma (EC).
People also ask
Is Frontiers in Oncology a journal?
What are the causes of cancer?
Oncol.</journal-id> <journal-title>Frontiers in ... 10.3389/fonc.2022.823018</article-id> <article-categories> ... Oncology</article-title>. <source>Nat Rev Clin ...
Highlights research in carcinogenesis and tumor progression, bridging the gap between basic research and clinical applications to advance diagnosis, ...
Missing: 2022.823018/ | Show results with:2022.823018/
Deleted in liver cancer 1 (DLC1) is confirmed as a metastasis suppressor gene in endometrial carcinoma (EC). However, its functional mechanisms remain unclear.
Highlights research in carcinogenesis and tumor progression, bridging the gap between basic research and clinical applications to advance diagnosis, ...
Missing: 2022.823018/ | Show results with:2022.823018/
Jul 29, 2022 · Chemotherapy has historically been the mainstay of cancer treatment, but our understanding of what drives a successful therapeutic response ...
Missing: 2022.823018/ | Show results with:2022.823018/
Feb 11, 2022 · Background and Aim Deleted in liver cancer 1 (DLC1) is confirmed as a metastasis suppressor gene in endometrial carcinoma (EC).
Research has found that cancer and metastases exhibit abnormal expression of numerous non-coding RNA. Some of these RNA facilitate prostate ...
Missing: 2022.823018/ | Show results with:2022.823018/
Dec 21, 2023 · Discussion: We conclude that the PODO447 glycoepitope is an excellent biomarker of immune “cold” tumors and a candidate for the development of ...
Missing: 2022.823018/ | Show results with:2022.823018/
Full text. Journal: Cancers, 2019, № 11, p. 1734 ... Publications that cite this publication ... https://doi.org/10.3389/fonc.2022.823018 ·. 2022, Frontiers in ...
Missing: articles/ | Show results with:articles/